Shaping Treatment Strategies: Insights into the Tumor Ecosystem | Dr. Ari Hakimi | KCRS23 Discussion [Video]

Join kidney cancer patient Adam Stern in an insightful conversation with Dr. Ari Hakimi from Memorial Sloan Kettering Cancer Center as they delve into the complexities of the tumor microenvironment and its impact on treatment strategies. Dr. Hakimi provides valuable insights into how understanding the tumor ecosystem can inform evolving treatment approaches for kidney cancer patients. Whether you’re a researcher seeking cutting-edge insights or a patient interested in understanding treatment dynamics, this discussion offers invaluable perspectives. Register now for KCRS24 at kcrs.kidneycan.org to explore more about the latest advancements in kidney cancer research.

You can view the entire KCRS23 presentations and their corresponding slides at: https://kcrs.kidneycan.org/kcrs23-presentations-video-slides/

KidneyCAN hosted the fifth annual Kidney Cancer Research Summit on July 13-14, 2023. #KCRS23 is a meeting of clinicians, researchers, research advocates, scientists, medical oncologists, industry and others to discuss the future efforts for collaboration in the field of kidney cancer research.

Learn more about KCRS and register for 2024 at https://kcrs.kidneycan.org

—————————————————————————
KidneyCAN is a registered 501(c)(3) nonprofit grassroots organization dedicated to funding and finding a cure for kidney cancer. The mission of KidneyCAN is to abolish kidney cancer as a threat to the life and health of patients by supporting patient advocacy and research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas.

Learn more about KidneyCAN at https://kidneycan.org
Support our mission: https://kidneycan.org/donate-now/

Together, we are accelerating cures for #kidneycancer.